Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jul 26.
Published in final edited form as: Breast Cancer Res Treat. 2016 Jun 28;158(2):351–359. doi: 10.1007/s10549-016-3884-y

Reproductive factors related to childbearing and mammographic breast density

Lusine Yaghjyan 1, Graham A Colditz 2,3, Bernard Rosner 4, Kimberly A Bertrand 5, Rulla M Tamimi 4
PMCID: PMC5527672  NIHMSID: NIHMS883302  PMID: 27351801

Abstract

Purpose

We investigated the associations of reproductive factors related to childbearing with percent breast density, absolute dense and non-dense areas, by menopausal status.

Methods

This study included 4,110 cancer-free women within the Nurses’ Health Study and Nurses’ Health Study II cohorts. Percent breast density, absolute dense and non-dense areas were measured from digitized mammography film images with computerized techniques. All density measures were square root-transformed in all the analyses to improve normality. The data on reproductive variables and other breast cancer risk factors were obtained from biennial questionnaires, at the time of the mammogram date.

Results

As compared to nulliparous women, parous postmenopausal women had lower percent density (β= −0.60, 95% CI −0.84; −0.37), smaller absolute dense area (β= −0.66, 95% CI −1.03; −0.29), and greater non-dense area (β=0.72, 95% CI 0.27; 1.16). Among parous women, number of children was inversely associated with percent density in pre- (β per one child=−0.12, 95% CI −0.20; −0.05) and postmenopausal women (β per one child=−0.07, 95% CI −0.12; −0.02). The positive associations of breastfeeding with absolute dense and non-dense areas were limited to premenopausal women, while the positive association of the age at first child’s birth with percent density and the inverse association with non-dense area were limited to postmenopausal women.

Conclusions

Women with greater number of children and younger age at first child’s birth have more favorable breast density patterns that could explain subsequent breast cancer risk reduction.

Keywords: parity, breastfeeding, age at first child, breast density, risk prediction

Introduction

High mammographic breast density is a well-established and strong predictor of breast cancer risk [14]. Appearance of the breast on a mammogram is a reflection of the amount of fat, connective tissue, and epithelial tissue in the breast [3]. Light (non-radiolucent) areas on the mammogram represent the fibrous and glandular tissues (“radiographically dense”), whereas, the dark (radiolucent) areas are primarily fat. Women with breasts of 75% or greater percent density (proportion of the total breast area that appears dense on the mammogram) are at 4- to 6-fold greater risk of breast cancer compared to women with more fat tissues in the breasts [3, 5, 6]. Absolute dense area of the breast that represents fibroglandular tissue has been shown to be positively associated with breast cancer risk in both pre- and postmenopausal women [713], while findings for the association between non-dense area of the breast (representing adipose tissue) and breast cancer risk have been conflicting [7, 9, 14, 15].

Reproductive factors related to childbearing have been associated with the risk of breast cancer in the previous studies. Parity has been shown to decrease the risk of estrogen and progesterone receptor-positive breast tumors [16]. Breastfeeding, on the other hand, was shown to reduce the risk of both receptor-positive and receptor-negative tumors, suggesting that the mechanisms behind these effects could be different [17]. Younger age at first birth was associated with reduced breast cancer risk [1820].

A few studies examined associations of these reproductive risk factors with mammographic breast density. Parity and younger age at first birth have been inversely associated with breast density in previous reports [21, 22]. A recent study found a positive association between duration of breastfeeding and breast density (measured as percent fibroglandular volume assessed using single-energy X-ray absorptiometry) [23]. To date, the effects of these reproductive variables on breast density remain poorly understood.

Previous studies suggested that a longer period between menarche and first pregnancy is associated with increased breast cancer risk in pre- and postmenopausal women [2427]. During this period the breast remains susceptible to carcinogenic influences until it undergoes final differentiation with permanent protective alterations in gene expression patterns during the first full-term pregnancy [2831]. Whether the length of this interval could influence adult breast density is unknown.

We aimed to assess the associations of several reproductive variables (breastfeeding, parity, age at first and last birth, and duration of the time between menarche and first birth) with percent density, absolute dense and non-dense areas in pre- and postmenopausal women using prospective data in cancer-free women from the Nurses’ Health Study and Nurses’ Health Study II.

Materials and Methods

Study population

Women included in this study were selected from participants of the nested case-control study within Nurses’ Health Study (NHS) and Nurses’ Health Study II (NHSII) cohorts. These prospective cohorts followed registered nurses in the United States who were 30–55 years (NHS) or 25–42 years old (NHSII) at enrollment. After administration of the initial questionnaire, the information on breast cancer risk factors and any diagnoses of cancer or other diseases was updated through biennial questionnaires [3, 32].

A nested case-control approach was originally used as an efficient design to examine the association between endogenous hormones, breast density, and breast cancer risk [3]. Using incidence density sampling, women without cancer history (other than non-melanoma skin cancer) at the time of the case’s cancer diagnosis (controls) were matched 1:1 or 1:2 with women diagnosed with in situ or invasive breast cancer (cases) on age at the time of blood collection, menopausal status and postmenopausal hormone use (current vs. not current) at blood draw, and day/time of blood draw; for NHS II, additional matching included race/ethnicity and day in the luteal phase [33]. Our analysis was restricted to controls from this nested case-control study. We attempted to obtain mammograms closest to the time of blood collection from 6,361 controls. From these women, 5,028 women provided consent (79%) and of those, 4,342 women (86%) had a usable mammogram for density estimation. The final population included 4,110 women (82% of women providing consent). This study was approved by the Institutional Review Board at the Brigham and Women’s Hospital. Informed consent was obtained or implied by return of questionnaires.

Reproductive variables

The data on age at menarche, parity, age at first and last birth, and breastfeeding were available from baseline and biennial questionnaires, completed closest to the date of the mammogram. Age at first birth was categorized as <24, 24–29, and ≥30 years. Parity was defined both as a binary variable (nulliparous, parous) as well as categorical (1, 2, 3, and ≥4 children). Parity and age at first birth were also modeled as continuous variables. Lifetime duration of breastfeeding (sum of breastfeeding duration across all births) was classified as none to <1, 1–6, >6–12, >12–18, >18–24, >24–36, and >36 months. Age at last birth and the time interval between menarche and first birth were modeled as continuous variables.

Assessment of mammographic breast density

To quantify mammographic density, the craniocaudal views of both breasts for all mammograms in the NHS and for the first two batches of mammograms in the NHSII were digitized at 261 μm per pixel with a Lumisys 85 laser film scanner (Lumisys, Sunnyvale, California). The third batch of NHSII mammograms was digitized using a VIDAR CAD PRO Advantage scanner (VIDAR Systems Corporation; Herndon, VA) and comparable resolution of 150 dots per inch and 12 bit depth). The Cumulus software (University of Toronto, Toronto, Canada) was used for computer-assisted determination of the absolute dense area, non-dense area, and percent mammographic density [3, 34]. During this assessment, the observer was blinded to the participant’s case-control status. As reported previously, the measure of breast density from NHS mammograms was highly reproducible (within-person intraclass correlation coefficient=0.93) [3]. All NHSII images were read by a single reader in three batches of mammograms approximately two-three years apart. Although within batch reproducibility was high (interclass correlation coefficient≥0.90) [7], density measures varied across the NHSII batches. The density measures from the second and third batches of NHSII mammograms were therefore adjusted to account for the batch effect, as previously described [35].

Percent breast density was measured as percentage of the total area occupied by epithelial/stromal tissue (absolute dense area) divided by the total breast area. Because breast densities of the right and left breast for an individual woman are strongly correlated [34], the average density of both breasts was used in this analysis.

Covariate information

Information on breast cancer risk factors was obtained from the biennial questionnaires closest to the date of the mammogram. Women were considered to be postmenopausal if they reported: 1) no menstrual periods within the 12 months before blood collection with natural menopause, 2) bilateral oophorectomy, or 3) hysterectomy with one or both ovaries retained, and were 54 years or older for ever smokers or 56 years or older for never smokers [36, 37].

Statistical analysis

We used multivariate linear regression to examine the associations of parity, age at first and last birth, breastfeeding, and interval between menarche and first birth with percent density, absolute dense and non-dense areas. Because density measures were non-normally distributed, we used square root-transformed density values in all the regression analyses to improve normality. The analyses were performed separately in pre- and postmenopausal women. The risk estimates were adjusted for age, body mass index (BMI), race, a family history of breast cancer, a history of benign breast disease, alcohol use, age at menarche, and in postmenopausal women, for postmenopausal hormone use. Additionally, in the analysis of the association of breastfeeding and age at last birth with density, the estimates were adjusted for parity and age at first birth. In the analysis of the associations of parity and age at first birth, the risk estimates were mutually adjusted for these two variables. In the analysis for the interval between menarche and first birth, the estimates were adjusted for parity.

The analyses of all reproductive variables except nulliparity were limited to parous women only. Parity and age at first birth were modeled both as continuous and categorical and breastfeeding was modeled as categorical. The lowest category for parity (1 child), age at first birth (<24 years), and breastfeeding (0-<1 month) were used as the reference. To assess the overall trend for each of the categorical reproductive variables, we used respective medians within each category. Age at last birth and duration of the interval between menarche and first birth were modeled as continuous variables.

Differences in the associations of reproductive variables with breast density by menopausal status were evaluated with two-way interactions and using Wald Chi-square test. To test interactions of menopausal status with nulliparity, we modeled both of these variables as nominal. To test interactions of breastfeeding with menopausal status, we used respective medians within each of the breastfeeding categories to model the interaction. Other reproductive factors were modeled as continuous variables to test their interactions with menopausal status. Statistical significance in all the analyses was assessed at 0.05 level. Finally, as distribution of percent density in premenopausal women approximated normal distribution, we examined the association of untransformed percent density with reproductive variables in premenopausal women to assess the magnitude of these associations that might be clinically relevant. The analyses were performed using SAS software (version 9.2, SAS Institute, Cary, NC, USA).

Results

In this study of 4,110 cancer-free women, the average age at the mammogram was 53 years (range 30–84). A majority of the women were postmenopausal at the mammogram (2,250 or 54.7%) and of those, 44.5% were using postmenopausal hormones at the time of the mammogram. The majority of women were parous (86.6% for premenopausal and 91.1%, for postmenopausal). The majority of parous women had at least two children (83.6% for premenopausal and 91.0% for postmenopausal) and breastfed for at least one month (76.2% for premenopausal and 60.0% for postmenopausal). The average age at first birth was 26 years (range 15–45) for premenopausal women and 25 years (range 15–40) for postmenopausal women. Age-adjusted characteristics of pre- and postmenopausal women in the study by nulliparous status are presented in Table 1.

Table 1.

Age-adjusted characteristics of the study population at the time of the mammogram

Characteristic Premenopausal Postmenopausal

Nulliparous (n=248) Parous (n=1600) Nulliparous (n=198) Parous (n=2034)
Mean (SD)
Percent mammographic density 40.7 (19.6) 39.2 (19.0) 31.1 (19.9) 25.3 (17.5)
Dense area (cm2) 88.2 (51.7) 80.6 (51.2 ) 61.0 (44.5) 47.9 (39.6)
Non-dense area (cm2) 147.7 (94.8) 134.8 (79.5) 158.3 (102.6) 156.3 (90.7)
Age (years)a 44.7 (4.2) 46.3 (4.4) 55.3 (8.5) 58.4 (7.7)
Age at menarche (years) 12.3 (1.4) 12.5 (1.4) 12.3 (1.3) 12.5 (1.4)
Age at menopause (years) NA NA 45.9 (6.8) 47.7 (5.9)
Body Mass Index (kg/m2) 25.9 (6.5) 25.5 (5.3) 27.3 (6.8) 26.2 (5.2)
Alcohol Use (grams) 6.4 (9.6) 4.3 (7.5) 6.0 (7.7) 5.0 (8.7)
Parity NA 2.5 (1.0) NA 3.1 (1.5)
Age at first birth (years) NA 26.1 (4.2) NA 25.1 (3.5)
Percentages
Family history of breast cancer 9 9 12 12
Benign breast disease 17 16 21 23
Never used PMH NA NA 30 35
Past PMH use NA NA 19 20
Current PMH use NA NA 50 44
Breastfeeding 0–<1 month NA 23 NA 39
Breastfeeding 1–6 months NA 16 NA 25
Breastfeeding >6–12 months NA 16 NA 12
Breastfeeding >12–18 months NA 13 NA 10
Breastfeeding >18–24 months NA 11 NA 5
Breastfeeding >24–36 months NA 12 NA 5
Breastfeeding >36 months NA 9 NA 3

Abbreviations: SD= standard deviation, PMH= postmenopausal hormone, NA-not applicable

Note: Values are means (SD) and percentages and are standardized to the age distribution of the study population.

a

Value is not age adjusted

Associations of reproductive variables with density measures in premenopausal women

Among premenopausal women, nulliparity was not associated with any of the density measures (Table 2). Although longer duration of breastfeeding was not associated with percent density (p-trend=0.52), longer duration was associated with larger areas of both absolute dense (β=0.10 per 6 months increase in breastfeeding duration, p-trend=0.01) and non-dense breast tissue (β=0.09 per 6 months increase in breastfeeding duration, p-trend=0.03) (Table 2). Among parous women, a greater number of children was associated with lower percent density (β per child=−0.12, 95% CI −0.20; −0.05) and larger area of non-dense tissue (β=0.20, 95% CI 0.07; 0.34). Associations of the other reproductive variables with density measures in premenopausal women were not significant.

Table 2.

Associations of reproductive variables related to childbearing with breast density measures a

Reproductive variable Premenopausal (n=1,860) Postmenopausal (n=2,250)

N Average Percent density Average Dense area Average Non-dense area N Average Percent density Average Dense area Average Non-dense area
Nulliparity b
Nulliparous 241 ref ref ref 195 ref ref ref
Parous 1557 −0.17 (−0.36; 0.02) −0.11 (−0.46; 0.23) 0.20 (−0.16; 0.56) 2010 −0.60 (−0.84; −0.37) −0.66 (−1.03; −0.29) 0.72 (0.27; 1.16)
Breast Feeding duration, months c
0–< 1 347 ref ref ref 789 ref ref ref
1–6 247 −0.22 (−0.46; 0.01) −0.34 (−0.75; 0.07) 0.12 (−0.32; 0.55) 498 −0.01 (−0.18; 0.17) −0.08 (−0.36; 0.19) −0.11 (−0.44; 0.22)
> 6–12 246 0.15 (−0.09; 0.38) 0.36 (−0.05; 0.78) 0.07 (−0.37; 0.50) 233 0.10 (−0.13; 0.33) 0.19 (−0.17; 0.55) 0.02 (0.41; 0.46)
>12–18 197 0.05 (−0.20; 0.31) 0.42 (−0.04; 0.87) 0.41 (−0.07; 0.88) 206 0.07 (−0.17; 0.31) −0.05 (−0.42; 0.33) −0.03 (−0.49; 0.43)
>18–24 160 0.02 (−0.25; 0.30) 0.29 (−0.19; 0.78) 0.31 (−0.20; 0.82) 104 −0.07 (−0.39; 0.26) 0.10 (−0.41; 0.61) 0.32 (−0.30; 0.93)
>24–36 187 −0.09 (−0.35; 0.18) 0.16 (−0.31; 0.64) 0.47 (−0.03; 0.97) 104 0.18 (−0.15; 0.51) 0.19 (−0.33; 0.70) −0.17 (−0.79; 0.46)
>36 142 0.10 (−0.21; 0.41) 0.61 (0.06; 1.15) 0.49 (−0.09; 1.06) 52 −0.11 (−0.56; 0.33) 0.22 (−0.48; 0.92) 1.24 (0.39; 2.08)
p-trendd 1526 0.52 0.01 0.03 1986 0.69 0.32 0.08
Parity e
1 211 ref ref ref 180 ref ref ref
2 699 −0.05 (−0.27; 0.17) −0.01 (−0.41; 0.38) −0.01 (−0.43; 0.40) 599 −0.02 (−0.28; 0.25) −0.16 (−0.58; 0.25) −0.41 − (−0.92; 0.09)
3 432 −0.13 (−0.38; 0.12) −0.24 (−0.67; 0.20) 0.07 (−0.39; 0.53) 566 −0.18 (−0.46; 0.10) −0.24 (−0.68; 0.19) −0.16 (−0.68; 0.36)
≥4 212 −0.37 (−0.66; −0.09) −0.34 (−0.85; 0.17) 0.57 (0.03; 1.10) 664 −0.27 (−0.55; 0.01) −0.59 (−1.03; −0.14) −0.55 (−1.09; −0.02)
p-trend 1554 0.01 0.07 0.03 2009 0.01 <0.01 0.13
Parity (continuous) e 1554 −0.12 (−0.20; −0.05) −0.13 (−0.26; 0.00) 0.20 (0.07; 0.34) 2009 −0.07 (−0.12; −0.02) −0.14 (−0.21; −0.06) −0.10 − (−0.20; −0.01)
Age at first birth, years f
<24 436 ref ref ref 723 ref ref ref
24–29 848 0.15 (−0.02; 0.31) 0.16 (−0.14; 0.46) −0.04 (−0.35; 0.27) 1069 0.14 (−0.01; 0.29) 0.01 (−0.22; 0.25) −0.45 (−0.73; −0.17)
≥30 270 0.12 (−0.11; 0.36) 0.05 (−0.37; 0.46) −0.19 (−0.63; 0.24) 217 0.28 (0.03; 0.53) 0.07 (−0.32; 0.46) −0.82 (−1.29; −0.34)
p-trend c 1554 0.28 0.78 0.39 2009 0.02 0.75 <0.001
Age at first birth (continuous, years) f 1554 0.01 (−0.01; 0.02) −0.00 (−0.03; 0.03) −0.01 (−0.04; 0.02) 2009 0.03 (0.01; 0.05) 0.01 (−0.02; 0.04) −0.10 (−0.13; −0.06)
Age at last birth, years c 1554 0.01 (−0.02; 0.03) −0.01 (−0.06; 0.03) −0.02 (−0.06; 0.03) 2009 0.00 (−0.02; 0.02) −0.03 (−0.07; 0.00) −0.08 (−0.12; −0.04)
Time between menarche and age at first birth, years g 1554 −0.00 (−0.02; 0.02) −0.00 (−0.04; 0.03) 0.00 (−0.03; 0.04) 2009 0.03 (0.01; 0.05) 0.02 (−0.01; 0.05) −0.07 (−0.11; −0.04)
a

All density measures are square root-transformed

b

Adjusted for age (continuous), BMI (continuous), race (White, other), age at menarche (<12, 12, 13, >13), a family history of breast cancer (Yes/No), a history of benign breast disease (Yes/No), NHS cohort (NHSI, NHSII), and alcohol use (none, >0–<5, ≥5 g/day); for postmenopausal women additionally adjusted for postmenopausal hormone use (none, past, current, past/unknown current)

c

Among parous women; adjusted for age (continuous), BMI (continuous), race (White, other), age at menarche (<12, 12, 13, >13), parity, age at first birth, a family history of breast cancer (Yes/No), a history of benign breast disease (Yes/No), NHS cohort(NHSI, NHSII), and alcohol use (none, >0–<5, ≥5 g/day); for postmenopausal women additionally adjusted for postmenopausal hormone use (none, past, current, past/unknown current)

d

P values were calculated using medians within respective categories

e

Among parous women; adjusted for age (continuous), BMI (continuous), race (White, other), age at first birth, age at menarche (<12, 12, 13, >13), a family history of breast cancer (Yes/No), a history of benign breast disease (Yes/No), NHS cohort(NHSI, NHSII), and alcohol use (none, >0–<5, ≥5 g/day); for postmenopausal women additionally adjusted for postmenopausal hormone use (none, past, current, past/unknown current)

f

Among parous women; adjusted for age (continuous), BMI (continuous), race (White, other), parity, age at menarche (<12, 12, 13, >13), a family history of breast cancer (Yes/No), a history of benign breast disease (Yes/No), NHS cohort(NHSI, NHSII), and alcohol use (none, >0–<5, ≥5 g/day); for postmenopausal women additionally adjusted for postmenopausal hormone use (none, past, current, past/unknown current)

g

Among parous women; adjusted for age (continuous), BMI (continuous), race (White, other), parity, a family history of breast cancer (Yes/No), a history of benign breast disease (Yes/No), NHS cohort(NHSI, NHSII), and alcohol use (none, >0–<5, ≥5 g/day); for postmenopausal women additionally adjusted for postmenopausal hormone use (none, past, current, past/unknown current)

In a secondary analysis with untransformed percent density in premenopausal women, having four or more children was associated with 5% decrease in percent density. On average, parous premenopausal women had 2.5% lower percent density as compared to nulliparous women. The magnitude of the associations of percent density with other reproductive variables did not exceed 2%.

Associations of reproductive variables with density measures in postmenopausal women

In postmenopausal women, parous women had lower percent density (β= −0.60, 95% CI −0.84; −0.37), smaller absolute dense area (β= −0.66, 95% CI −1.03; −0.29), and larger non-dense area (β=0.72; 95% CI 0.27; 1.16) as compared to nulliparous women (Table 2). These associations were stronger than in premenopausal women (p-interaction<0.001, 0.04, and 0.01, respectively). Among parous women, older age at first birth was positively associated with percent density (β=0.03, 95% CI 0.01; 0.05) and inversely associated with non-dense area (β= −0.10, 95% CI −0.13; −0.06). Among parous women, a greater number of children was associated with lower percent density (β= −0.07, 95% CI −0.12; −0.02) and smaller absolute dense (β= −0.14, 95% CI −0.21; −0.06) and non-dense area (β= −0.10, 95% CI −0.20; −0.01). Older age at last birth was associated with smaller non-dense area (β= −0.08; 95% CI −0.12; −0.04, p-interaction with menopausal status<0.01). Finally, a longer interval between menarche and first birth was positively associated with percent density (β=0.03, 95% CI 0.01; 0.05, p-interaction with menopausal status=0.03) and inversely associated with non-dense area (β= −0.07, 95% CI −0.11; −0.04, p-interaction with menopausal status=0.01) (Table 2). Interactions of other reproductive factors with menopausal status did not reach statistical significance (p-interaction>0.05 for all).

Discussion

In this study of 4,110 cancer-free women, nulliparity, number of children, age at first and last birth, duration of breastfeeding, and duration of the interval between menarche and first birth were associated with breast density measures and these associations varied in pre- and postmenopausal women. The positive associations of breastfeeding with absolute dense and non-dense area were limited to premenopausal women, while the positive association of the age at first birth with percent density and inverse association with non-dense area, the inverse association of the age at last birth with non-dense area and the positive association of interval between menarche and first birth with percent density and inverse association with non-dense area were limited to postmenopausal women.

Our results on the association of parity and the age at first birth with percent breast density are consistent with previous reports. Modugno et al. found lower percent density in parous women as compared to nulliparous women among 239 postmenopausal women (age 70–92) (23.7 versus 34.7%, p=0.005), but did not find associations with the age at first birth and breastfeeding [38]. An inverse association of parity with woman’s life-long history of percent density was previously reported in the Fernald Community Cohort [22]. Nulliparity and an older age at first birth were associated with increased percent density in both premenopausal and postmenopausal women in a study of 1,900 women by Vachon et al. [21]. Changes in the cellular processes in the breast tissue during pregnancy have been suggested as possible mechanisms behind protective effect of pregnancy on breast cancer risk [39]. Pregnancy results in reduction in the number of stem cells which are responsible for life-long decrease in the mammary stem cell numbers in parous women, and thus a decrease in the pool of potentially transformable susceptible epithelial cells [16]. This theory is supported by emerging findings on the decrease in stem cell marker expression with increasing parity [40]. Tissue-specific stem cells serve as the source of the mature, functional cell types of a given tissue, have the capacity for self-renewal, and have ability to regenerate its “home” tissue in its entirety [4146]. Reduction in the number of these stem cells might explain the decrease in breast density in parous women. On the other hand, an older age at the first birth leaves the undifferentiated breast tissue more susceptible to influences of exogenous and endogenous hormonal effects some of which have potential to increase epithelial proliferation and subsequently breast density [28, 29]. Whether this mechanism could explain increase in breast density with an older age at the first child’s birth yet need to be explored.

We examine, for the first time, the associations of several reproductive variables related to childbearing with absolute dense and non-dense area. Our findings suggest that among both pre- and postmenopausal women, parity is inversely associated with both percent density and absolute dense area. In contrast, parity is positively associated with non-dense area among premenopausal women and inversely associated with non-dense area among postmenopausal women, which could explain the differences in the strength of associations with percent density by menopausal status.

We found a positive association of breastfeeding with both absolute dense and non-dense areas in premenopausal women. There were no associations in postmenopausal women suggesting that the effects of breastfeeding on breast tissue are likely temporary. In a previous study by Prebil et al., duration of breastfeeding was positively associated with fibro-glandular volume among 2440 parous women (β for square root-transformed fibro-glandular volume= 0.01, 95% CI 0.003; 0.02) [23]. Studies on breast tissue remodeling after lactation in humans are very limited, but animal reports suggest that with discontinuation of lactation, the breast tissue undergoes postpartum involution and remodeling as the result of apoptosis, regression of alveoli, and adipocyte repopulation [47, 48]. This mechanism, if confirmed in human studies, could potentially explain the increase in non-dense area in women with longer duration of breastfeeding as after longer duration a larger area of epithelium will undergo remodeling and replacement with adipose tissue (non-dense tissue on the mammogram).

To our knowledge, this is the largest study to date that simultaneously explored associations of several reproductive variables with percent density, absolute dense, and non-dense areas in pre- and postmenopausal women. The analysis used data from the Nurses’ Health Study and Nurses’ Health Study II, established cohorts with more than 30 years of follow-up, ascertainment of disease status, and comprehensive information on breast cancer risk factors and breast density. Our study has a few limitations. The examined associations are based on the density measures from a single mammogram which might not be reflective of the woman’s life-long density pattern. Despite the prospective nature of the cohort, the recall bias for selected reproductive variables especially in postmenopausal women is possible. For example, previous studies had conflicting findings on the accuracy of recall for age at menarche [4951] which could potentially influence the results for associations of the interval between menarche and first birth with density measures. Some reports suggest that recall bias for breastfeeding in older women can affect the estimated associations between breastfeeding and health outcomes [52] and its influence on the null results among postmenopausal women in our study population should be acknowledged.

In conclusion, we investigated the associations of several reproductive variables related to childbearing with percent density, absolute dense and non-dense areas. Our findings suggest that nulliparous women are more likely to have high-risk breast density patterns as compared to parous women. Parous women with greater number of children and younger age at first birth have more favorable breast density patterns (lower percent density, smaller absolute dense area, and larger non-dense area) that could explain subsequent breast cancer risk reduction. The biological mechanisms underlying the associations of reproductive factors with density patterns yet need to be elucidated.

Acknowledgments

This study was supported by the National Institutes of Health (grant number CA131332 to R.M.T., CA175080 to R.M.T., CA087969 to R.M.T., UM1 CA186107 to M.S., UM1 CA176726 to W.W.); Department of Health and Human Services; Avon Foundation for Women; Susan G. Komen for the Curereg;; and Breast Cancer Research Foundation. Dr. Colditz is supported in part by an American Cancer Society Cissy Hornung Clinical Research Professorship. Dr. Bertrand was supported in part by the Simeon J. Fortin Charitable Foundation, Bank of America, N.A., Co-Trustee.

Footnotes

Compliance with ethical standards

This study was approved by the Institutional Review Board at the Brigham and Women’s Hospital. Informed consent was obtained or implied by return of questionnaires.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  • 1.Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6(10):798–808. doi: 10.1016/S1470-2045(05)70390-9. [DOI] [PubMed] [Google Scholar]
  • 2.Ginsburg OM, Martin LJ, Boyd NF. Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer. 2008;99(9):1369–1374. doi: 10.1038/sj.bjc.6604635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007;99(15):1178–1187. doi: 10.1093/jnci/djm062. [DOI] [PubMed] [Google Scholar]
  • 4.Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology. 2004;230(1):29–41. doi: 10.1148/radiol.2301020870. [DOI] [PubMed] [Google Scholar]
  • 5.Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995;87(9):670–675. doi: 10.1093/jnci/87.9.670. [DOI] [PubMed] [Google Scholar]
  • 6.Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87(21):1622–1629. doi: 10.1093/jnci/87.21.1622. [DOI] [PubMed] [Google Scholar]
  • 7.Pettersson A, Hankinson S, Willett W, Lagiou P, Trichopoulos D, Tamimi R. Nondense mammographic area and risk of breast cancer. Breast Cancer Research. 2011;13(5):R100. doi: 10.1186/bcr3041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Aitken Z, McCormack VA, Highnam RP, Martin L, Gunasekara A, Melnichouk O, Mawdsley G, Peressotti C, Yaffe M, Boyd NF, dos Santos Silva I. Screen-Film Mammographic Density and Breast Cancer Risk: A Comparison of the Volumetric Standard Mammogram Form and the Interactive Threshold Measurement Methods. Cancer Epidemiology Biomarkers & Prevention. 2010;19(2):418–428. doi: 10.1158/1055-9965.EPI-09-1059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Stone J, Ding J, Warren RM, Duffy SW, Hopper JL. Using mammographic density to predict breast cancer risk: dense area or percentage dense area. Breast Cancer Res. 2010;12(6):R97. doi: 10.1186/bcr2778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC. Mammographic Density and Breast Cancer in Three Ethnic Groups. Cancer Epidemiology Biomarkers & Prevention. 2003;12(4):332–338. [PubMed] [Google Scholar]
  • 11.Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN. Mammographic Density and Breast Cancer Risk. American Journal of Epidemiology. 2005;162(8):743–752. doi: 10.1093/aje/kwi270. [DOI] [PubMed] [Google Scholar]
  • 12.Boyd N, Martin L, Gunasekara A, Melnichouk O, Maudsley G, Peressotti C, Yaffe M, Minkin S. Mammographic Density and Breast Cancer Risk: Evaluation of a Novel Method of Measuring Breast Tissue Volumes. Cancer Epidemiology Biomarkers & Prevention. 2009;18(6):1754–1762. doi: 10.1158/1055-9965.EPI-09-0107. [DOI] [PubMed] [Google Scholar]
  • 13.Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Sellers TA. Mammographic Breast Density as a General Marker of Breast Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 2007;16(1):43–49. doi: 10.1158/1055-9965.EPI-06-0738. [DOI] [PubMed] [Google Scholar]
  • 14.Lokate M, Peeters PH, Peelen LM, Haars G, Veldhuis WB, van Gils CH. Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res. 2011;13(5):R103. doi: 10.1186/bcr3044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, Vachon C, Bakker MF, Giles GG, Chia KS, Czene K, Eriksson L, Hall P, Hartman M, Warren RM, Hislop G, Chiarelli AM, Hopper JL, Krishnan K, Li J, Li Q, Pagano I, Rosner BA, Wong CS, Scott C, Stone J, Maskarinec G, Boyd NF, van Gils CH, Tamimi RM. Mammographic Density Phenotypes and Risk of Breast Cancer: A Meta-analysis. J Natl Cancer Inst. 2014 doi: 10.1093/jnci/dju078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Britt K, Ashworth A, Smalley M. Pregnancy and the risk of breast cancer. Endocr Relat Cancer. 2007;14(4):907–933. doi: 10.1677/ERC-07-0137. [DOI] [PubMed] [Google Scholar]
  • 17.Morris GJ. Breastfeeding, parity, and reduction of breast cancer risk. Breast J. 2009;15(5):562–563. doi: 10.1111/j.1524-4741.2009.00787.x. [DOI] [PubMed] [Google Scholar]
  • 18.MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S. Age at first birth and breast cancer risk. Bulletin of the World Health Organization. 1970;43:209–221. [PMC free article] [PubMed] [Google Scholar]
  • 19.Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S. Age at any birth and breast cancer risk. International Journal of Cancer. 1983;31:701–704. doi: 10.1002/ijc.2910310604. [DOI] [PubMed] [Google Scholar]
  • 20.Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36–47. doi: 10.1093/oxfordjournals.epirev.a036115. [DOI] [PubMed] [Google Scholar]
  • 21.Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States) Cancer Causes Control. 2000;11(7):653–662. doi: 10.1023/a:1008926607428. [DOI] [PubMed] [Google Scholar]
  • 22.Yaghjyan L, Mahoney MC, Succop P, Wones R, Buckholz J, Pinney SM. Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. Br J Cancer. 2012 doi: 10.1038/bjc.2012.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Prebil L, Ereman R, Powell M, Jamshidian F, Kerlikowske K, Shepherd J, Hurlbert M, Benz C. First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes & Control. 2014;25(7):859–868. doi: 10.1007/s10552-014-0386-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G, Burkman RT, Folger SG, Norman S, McDonald JA, Spirtas R. Timing of menarche and first full-term birth in relation to breast cancer risk. American journal of epidemiology. 2008;167(2):230–239. doi: 10.1093/aje/kwm271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ritte R, Tikk K, Lukanova A, Tjonneland A, Olsen A, Overvad K, Dossus L, Fournier A, Clavel-Chapelon F, Grote V, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Berrino F, Mattiello A, Tumino R, Sacerdote C, Quiros JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Wareham N, Khaw KT, Key TJ, Travis RC, Weiderpass E, Dumeaux V, Lund E, Sund M, Andersson A, Romieu I, Rinaldi S, Vineis P, Merritt MA, Riboli E, Kaaks R. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study. BMC Cancer. 2013;13:584. doi: 10.1186/1471-2407-13-584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Rosner B, Colditz GA. Nurses’ health study: log-incidence mathematical model of breast cancer incidence. Journal of the National Cancer Institute. 1996;88(6):359–364. doi: 10.1093/jnci/88.6.359. [DOI] [PubMed] [Google Scholar]
  • 27.Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature. 1983;303(5920):767–770. doi: 10.1038/303767a0. [DOI] [PubMed] [Google Scholar]
  • 28.Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6(5):213–218. doi: 10.1186/bcr921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005;7(3):131–142. doi: 10.1186/bcr1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Colditz GA, Bohlke K. Priorities for the primary prevention of breast cancer. CA Cancer J Clin. 2014;64(3):186–194. doi: 10.3322/caac.21225. [DOI] [PubMed] [Google Scholar]
  • 31.Biro FM, Deardorff J. Identifying opportunities for cancer prevention during preadolescence and adolescence: puberty as a window of susceptibility. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2013;52(5 Suppl):S15–20. doi: 10.1016/j.jadohealth.2012.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Colditz GA, Hankinson SE. The Nurses’ Health Study: lifestyle and health among women. Nature reviews Cancer. 2005;5(5):388–396. doi: 10.1038/nrc1608. [DOI] [PubMed] [Google Scholar]
  • 33.Bertrand KA, Rosner B, Eliassen AH, Hankinson SE, Rexrode KM, Willett W, Tamimi RM. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer. Breast Cancer Res Treat. 2015;149(2):479–487. doi: 10.1007/s10549-014-3247-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Byng JW, Boyd NF, Little L, Lockwood G, Fishell E, Jong RA, Yaffe MJ. Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev. 1996;5(5):319–327. doi: 10.1097/00008469-199610000-00003. [DOI] [PubMed] [Google Scholar]
  • 35.Bertrand K, Eliassen AH, Hankinson S, Gierach G, Xu X, Rosner B, Ziegler R, Tamimi R. Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women. Breast Cancer Research and Treatment. 2012;136(1):277–287. doi: 10.1007/s10549-012-2240-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B, Cramer D, Hennekens CH. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983;117(6):651–658. doi: 10.1093/oxfordjournals.aje.a113598. [DOI] [PubMed] [Google Scholar]
  • 37.Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease. New England Journal of Medicine. 1985;313(17):1044–1049. doi: 10.1056/NEJM198510243131703. [DOI] [PubMed] [Google Scholar]
  • 38.Modugno F, Ngo DL, Allen GO, Kuller LH, Ness RB, Vogel VG, Costantino JP, Cauley JA. Breast cancer risk factors and mammographic breast density in women over age 70. Breast Cancer Res Treat. 2006;97(2):157–166. doi: 10.1007/s10549-005-9105-8. [DOI] [PubMed] [Google Scholar]
  • 39.Meier-Abt F, Bentires-Alj M, Rochlitz C. Breast Cancer Prevention: Lessons to be Learned from Mechanisms of Early Pregnancy–Mediated Breast Cancer Protection. Cancer Research. 2015;75(5):803–807. doi: 10.1158/0008-5472.CAN-14-2717. [DOI] [PubMed] [Google Scholar]
  • 40.Isfoss B, Holmqvist B, Jernström H, Alm P, Olsson H. Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules. BMC Clin Pathol. 2013;13(1):1–9. doi: 10.1186/1472-6890-13-28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Savarese TM, Low HP, Baik I, Strohsnitter WC, Hsieh CC. Normal breast stem cells, malignant breast stem cells, and the perinatal origin of breast cancer. Stem Cell Rev. 2006;2(2):103–110. doi: 10.1007/s12015-006-0016-9. [DOI] [PubMed] [Google Scholar]
  • 42.Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development. 1998;125(10):1921–1930. doi: 10.1242/dev.125.10.1921. [DOI] [PubMed] [Google Scholar]
  • 43.Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. Generation of a functional mammary gland from a single stem cell. Nature. 2006;439(7072):84–88. doi: 10.1038/nature04372. [DOI] [PubMed] [Google Scholar]
  • 44.Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. Purification and unique properties of mammary epithelial stem cells. Nature. 2006;439(7079):993–997. doi: 10.1038/nature04496. [DOI] [PubMed] [Google Scholar]
  • 45.Cobaleda C, Cruz JJ, Gonzalez-Sarmiento R, Sanchez-Garcia I, Perez-Losada J. The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease. Stem Cell Rev. 2008;4(2):67–79. doi: 10.1007/s12015-008-9012-6. [DOI] [PubMed] [Google Scholar]
  • 46.Dontu G. Breast cancer stem cell markers - the rocky road to clinical applications. Breast Cancer Res. 2008;10(5):110. doi: 10.1186/bcr2130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Radisky DC, Hartmann LC. Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia. 2009;14(2):181–191. doi: 10.1007/s10911-009-9123-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.O’Brien J, Martinson H, Durand-Rougely C, Schedin P. Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development. 2012;139(2):269–275. doi: 10.1242/dev.071696. [DOI] [PubMed] [Google Scholar]
  • 49.Must A, Phillips SM, Naumova EN, Blum M, Harris S, Dawson-Hughes B, Rand WM. Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember? Am J Epidemiol. 2002;155(7):672–679. doi: 10.1093/aje/155.7.672. [DOI] [PubMed] [Google Scholar]
  • 50.Koprowski C, Coates RJ, Bernstein L. Ability of young women to recall past body size and age at menarche. Obes Res. 2001;9(8):478–485. doi: 10.1038/oby.2001.62. [DOI] [PubMed] [Google Scholar]
  • 51.Cooper R, Blell M, Hardy R, Black S, Pollard TM, Wadsworth MEJ, Pearce MS, Kuh D. Validity of age at menarche self-reported in adulthood. Journal of Epidemiology and Community Health. 2006;60(11):993–997. doi: 10.1136/jech.2005.043182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Promislow JH, Gladen BC, Sandler DP. Maternal recall of breastfeeding duration by elderly women. Am J Epidemiol. 2005;161(3):289–296. doi: 10.1093/aje/kwi044. [DOI] [PubMed] [Google Scholar]

RESOURCES